Microbial and host immune factors as drivers of COPD

Moana Mika, Izabela Nita, Laura Morf, Weihong Qi, Seraina Beyeler, Eric Bernasconi, Benjamin J. Marsland, Sebastian R. Ott, Christophe von Garnier, Markus Hilty

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Compartmentalisation of the respiratory tract microbiota in patients with different chronic obstructive pulmonary disease (COPD) severity degrees needs to be systematically investigated. In addition, it is unknown if the inflammatory and emphysematous milieux in patients with COPD are associated with changes in the respiratory tract microbiota and host macrophage gene expression. We performed a cross-sectional study to compare non-COPD controls (n=10) to COPD patients (n=32) with different disease severity degrees. Samples (n=187) were obtained from different sites of the upper and lower respiratory tract. Microbiota analyses were performed by 16S ribosomal RNA gene sequencing and host gene expression analyses by quantitative real-time PCR of distinct markers of bronchoalveolar lavage cells. Overall, the microbial communities of severe COPD (Global Initiative for Chronic Obstructive Lung Disease (GOLD) grade 3/4) patients clustered significantly differently to controls and less severe COPD (GOLD 1/2) patients (permutational multivariate ANOVA (MANOVA), p=0.001). However, we could not detect significant associations between the different sampling sites in the lower airways. In addition, the chosen set of host gene expression markers significantly separated COPD GOLD 3/4 patients, and we found correlations between the composition of the microbiota and the host data. In conclusion, this study demonstrates associations between host gene expression and microbiota profiles that may influence the course of COPD.

Original languageEnglish
Article number00015-2018
Number of pages10
JournalERJ Open Research
Volume4
Issue number3
DOIs
Publication statusPublished - 1 Jul 2018
Externally publishedYes

Cite this

Mika, M., Nita, I., Morf, L., Qi, W., Beyeler, S., Bernasconi, E., ... Hilty, M. (2018). Microbial and host immune factors as drivers of COPD. ERJ Open Research, 4(3), [00015-2018]. https://doi.org/10.1183/23120541.00015-2018
Mika, Moana ; Nita, Izabela ; Morf, Laura ; Qi, Weihong ; Beyeler, Seraina ; Bernasconi, Eric ; Marsland, Benjamin J. ; Ott, Sebastian R. ; von Garnier, Christophe ; Hilty, Markus. / Microbial and host immune factors as drivers of COPD. In: ERJ Open Research. 2018 ; Vol. 4, No. 3.
@article{2c18b6ebbaf74f49ab679e6a85759e05,
title = "Microbial and host immune factors as drivers of COPD",
abstract = "Compartmentalisation of the respiratory tract microbiota in patients with different chronic obstructive pulmonary disease (COPD) severity degrees needs to be systematically investigated. In addition, it is unknown if the inflammatory and emphysematous milieux in patients with COPD are associated with changes in the respiratory tract microbiota and host macrophage gene expression. We performed a cross-sectional study to compare non-COPD controls (n=10) to COPD patients (n=32) with different disease severity degrees. Samples (n=187) were obtained from different sites of the upper and lower respiratory tract. Microbiota analyses were performed by 16S ribosomal RNA gene sequencing and host gene expression analyses by quantitative real-time PCR of distinct markers of bronchoalveolar lavage cells. Overall, the microbial communities of severe COPD (Global Initiative for Chronic Obstructive Lung Disease (GOLD) grade 3/4) patients clustered significantly differently to controls and less severe COPD (GOLD 1/2) patients (permutational multivariate ANOVA (MANOVA), p=0.001). However, we could not detect significant associations between the different sampling sites in the lower airways. In addition, the chosen set of host gene expression markers significantly separated COPD GOLD 3/4 patients, and we found correlations between the composition of the microbiota and the host data. In conclusion, this study demonstrates associations between host gene expression and microbiota profiles that may influence the course of COPD.",
author = "Moana Mika and Izabela Nita and Laura Morf and Weihong Qi and Seraina Beyeler and Eric Bernasconi and Marsland, {Benjamin J.} and Ott, {Sebastian R.} and {von Garnier}, Christophe and Markus Hilty",
year = "2018",
month = "7",
day = "1",
doi = "10.1183/23120541.00015-2018",
language = "English",
volume = "4",
journal = "ERJ Open Research",
issn = "2312-0541",
publisher = "European Respiratory Society",
number = "3",

}

Mika, M, Nita, I, Morf, L, Qi, W, Beyeler, S, Bernasconi, E, Marsland, BJ, Ott, SR, von Garnier, C & Hilty, M 2018, 'Microbial and host immune factors as drivers of COPD' ERJ Open Research, vol. 4, no. 3, 00015-2018. https://doi.org/10.1183/23120541.00015-2018

Microbial and host immune factors as drivers of COPD. / Mika, Moana; Nita, Izabela; Morf, Laura; Qi, Weihong; Beyeler, Seraina; Bernasconi, Eric; Marsland, Benjamin J.; Ott, Sebastian R.; von Garnier, Christophe; Hilty, Markus.

In: ERJ Open Research, Vol. 4, No. 3, 00015-2018, 01.07.2018.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Microbial and host immune factors as drivers of COPD

AU - Mika, Moana

AU - Nita, Izabela

AU - Morf, Laura

AU - Qi, Weihong

AU - Beyeler, Seraina

AU - Bernasconi, Eric

AU - Marsland, Benjamin J.

AU - Ott, Sebastian R.

AU - von Garnier, Christophe

AU - Hilty, Markus

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Compartmentalisation of the respiratory tract microbiota in patients with different chronic obstructive pulmonary disease (COPD) severity degrees needs to be systematically investigated. In addition, it is unknown if the inflammatory and emphysematous milieux in patients with COPD are associated with changes in the respiratory tract microbiota and host macrophage gene expression. We performed a cross-sectional study to compare non-COPD controls (n=10) to COPD patients (n=32) with different disease severity degrees. Samples (n=187) were obtained from different sites of the upper and lower respiratory tract. Microbiota analyses were performed by 16S ribosomal RNA gene sequencing and host gene expression analyses by quantitative real-time PCR of distinct markers of bronchoalveolar lavage cells. Overall, the microbial communities of severe COPD (Global Initiative for Chronic Obstructive Lung Disease (GOLD) grade 3/4) patients clustered significantly differently to controls and less severe COPD (GOLD 1/2) patients (permutational multivariate ANOVA (MANOVA), p=0.001). However, we could not detect significant associations between the different sampling sites in the lower airways. In addition, the chosen set of host gene expression markers significantly separated COPD GOLD 3/4 patients, and we found correlations between the composition of the microbiota and the host data. In conclusion, this study demonstrates associations between host gene expression and microbiota profiles that may influence the course of COPD.

AB - Compartmentalisation of the respiratory tract microbiota in patients with different chronic obstructive pulmonary disease (COPD) severity degrees needs to be systematically investigated. In addition, it is unknown if the inflammatory and emphysematous milieux in patients with COPD are associated with changes in the respiratory tract microbiota and host macrophage gene expression. We performed a cross-sectional study to compare non-COPD controls (n=10) to COPD patients (n=32) with different disease severity degrees. Samples (n=187) were obtained from different sites of the upper and lower respiratory tract. Microbiota analyses were performed by 16S ribosomal RNA gene sequencing and host gene expression analyses by quantitative real-time PCR of distinct markers of bronchoalveolar lavage cells. Overall, the microbial communities of severe COPD (Global Initiative for Chronic Obstructive Lung Disease (GOLD) grade 3/4) patients clustered significantly differently to controls and less severe COPD (GOLD 1/2) patients (permutational multivariate ANOVA (MANOVA), p=0.001). However, we could not detect significant associations between the different sampling sites in the lower airways. In addition, the chosen set of host gene expression markers significantly separated COPD GOLD 3/4 patients, and we found correlations between the composition of the microbiota and the host data. In conclusion, this study demonstrates associations between host gene expression and microbiota profiles that may influence the course of COPD.

UR - http://www.scopus.com/inward/record.url?scp=85049693169&partnerID=8YFLogxK

U2 - 10.1183/23120541.00015-2018

DO - 10.1183/23120541.00015-2018

M3 - Article

VL - 4

JO - ERJ Open Research

JF - ERJ Open Research

SN - 2312-0541

IS - 3

M1 - 00015-2018

ER -

Mika M, Nita I, Morf L, Qi W, Beyeler S, Bernasconi E et al. Microbial and host immune factors as drivers of COPD. ERJ Open Research. 2018 Jul 1;4(3). 00015-2018. https://doi.org/10.1183/23120541.00015-2018